JPRN-jRCT2080221397未知3 期
Investigation of the Safety and Efficacy of JTT-751 in a Long-term Study in Hemodialysis Patients (1)
JAPAN TABACCO INC.0 个研究点目标入组 220 人开始时间: 2011年3月7日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients undergoing hemodialysis 3 times weekly
排除标准
- •Patients with gastrointestinal diseases, such as peptic ulcer
- •Patients with advanced cardiac disease, or with hepatic dysfunction
研究者
相似试验
未知
3 期
Investigation of the Safety and Efficacy of JTT-751 in a Long-term Study in Hemodialysis Patients (2)Chronic Kidney DiseaseJPRN-jRCT2080221398JAPAN TABACCO INC.150
未知
3 期
Investigation of the Safety and Efficacy of JTT-751 in Non-dialysis CKD Patients (Extension Study)Chronic Kidney DiseaseJPRN-jRCT2080221399JAPAN TABACCO INC.90
未知
3 期
Investigation of the Efficacy and Safety of JTT-751 in Non-dialysis CKD Patients (Double-blind Comparative Study)Chronic Kidney DiseaseJPRN-jRCT2080221396JAPAN TABACCO INC.90
未知
2 期
Investigation of the Efficacy and Safety of JTT-751in Hemodialysis PatientsChronic renal failureJPRN-jRCT2080220681JAPAN TABACCO INC.168
尚未招募
2 期
Investigation on efficacy and safety of TJ-50 for the patients with postoperative chronic sinusitisJPRN-UMIN000031689Yokohama city university medical center Otolaryngolgy40